Stock Events

Stock Events

SAB Biotherapeutics (SABS) Q2 2023 Earnings

21AugConfirmed

Aug 22

Nov 22

Q1 2023

Q2 2023

-0.17

-0.15

-0.13

-0.11

Details

Expected EPS

N/A

Actual EPS

-0.14

Surprise EPS

-0.14

Surprise Percent

+∞%

Description

SAB Biotherapeutics (SABS) has reported earnings of -0.14 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.